Apoptosis-inducing effect of spiroaminopyrimidine analogue in NB4 leukemia cells via down-regulation of BIRC5 expression
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-4.13749Keywords:
apoptosis, cell cycle, NB4 cell line, spiroaminopyrimidineAbstract
Summary. Aim: It has been reported that spiroaminopyrimidine derivatives inhibited the growth and proliferation of various cancer cell lines. In the present study, we evaluated cytotoxic and apoptosis-inducing effects of 2,4-diamino-1,3-diazaspiro[5.5]-9-tert-butyl-2, 4-diene-5-carbonitril (9-tBAP) on NB4 acute promyelocytic leukemia (APL) cells. Materials and Methods: The cells were treated with 10–100 µM of 9-tBAP. Cytotoxic activity of the compound was measured using the MTT assay. Apoptosis was investigated by Hoechst 33258 staining as well as by Annexin V/PI double staining. Results: The compound under study was found to be highly active cell growth inhibitor with IC50 of 30.0 ± 3.5 µM inducing apoptosis in NB4 cells. Cell cycle analysis by flow cytometry showed a time-dependent increase in sub-G1 cell population. Real-time polymerase chain reaction analysis revealed that the treatment with the compound down-regulated the BIRC5 expression in a time-dependent manner. Conclusion: 9-tBAP displayed potent anti-leukemic activity in vitro thus warranting further investigation.
References
Borutinskaitė V, Navakauskienė R. The histone deacetylase inhibitor BML-210 influences gene and protein expression in human promyelocytic leukemia NB4 cells via epigenetic reprogramming. Int J Mol Sci 2015; 16: 18252–69.
Zhu B, Wang J, Zhou F, et al. Zinc depletion by TPEN induces apoptosis in human acute promyelocytic NB4 cells. Cell Physiol Biochem 2017; 42: 1822–36.
Fares M, Abou-Seri SM, Abdel-Aziz HA, et al. Synthesis and antitumor activity of pyrido [2,3-d] pyrimidine and pyrido [2,3-d][1,2,4] triazolo [4,3-a] pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest. Eur J Med Chem 2014; 83: 155–66.
Aryapour H, Mahdavi M, Mohebbi SR, et al. Anti-proliferative and apoptotic effects of the derivatives from 4-aryl-4H-chromene family on human leukemia K562 cells. Arch Pharm Res 2012; 35: 1573–82.
Khan Z, Khan AA, Yadav H, et al. Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma. Cell Mol Biol Lett 2017; 22: 8.
Vischioni B, Van der Valk P, Span S, et al. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Ann Oncol 2004; 15: 1654–60.
El-Deeb IM, Lee S. Design and synthesis of new anticancer pyrimidines with multiple-kinase inhibitory effect. Bioorg Med Chem 2010; 18: 3860–74.
Sutherlin DP, Sampath D, Berry M, et al. Discovery of (thienopyrimidin-2-yl) aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer. J Med Chem 2010; 53: 1086–97.
Golemovic M, Verstovsek S, Giles F, et al. AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has in vitro activity against imatinib-resistant chronic myeloid leukemia. Clin Cancer Res 2005; 11: 4941–7.
Balalaie S, Moghimi H, Bararjanian M, et al. Efficient synthesis of spiroaminopyrimidones, and their anti-bacterial activities. J Heterocycl Chem 2013; 50: 1304–12.
Rahimi R, Mahdavi M, Pejman S, et al. Inhibition of cell proliferation and induction of apoptosis in K562 human leukemia cells by the derivative (3-NpC) from dihydro-pyranochromenes family. Acta Biochim Pol 2015; 62: 83–8.
Nicoletti I, Migliorati G, Pagliacci M, et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139: 271–9.
Yazdanparast R, Moosavi MA, Mahdavi M, et al. Guanosine 5′-triphosphate induces differentiation-dependent apoptosis in human leukemia U937 and KG1 cells. Acta Pharmacol Sin 2006; 27: 1175–84.
Hasanzadeh D, Mahdavi M, Dehghan G, et al. Farnesiferol C induces cell cycle arrest and apoptosis mediated by oxidative stress in MCF-7 cell line. Toxicol Rep 2017; 4: 420–6.
Finaurini S, Basilico N, Corbett Y, et al. Dihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle. Toxicology 2012; 300: 57–66.
Ghasemian M, Mahdavi M, Zare P, et al. Spiroquinazolinone-induced cytotoxicity and apoptosis in K562 human leukemia cells: alteration in expression levels of Bcl-2 and Bax. J Toxicol Sci 2015; 40: 115–26.
Singh H, Werner L, DeAngelo D, et al. Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutations. Am J Hematol 2010; 85: 956–7.
Mohamed MF, Abdelmoniem AM, Elwahy AH, et al. DNA fragmentation, cell cycle arrest, and docking study of novel bis spiro-cyclic 2-oxindole of pyrimido [4, 5-b] quinoline-4, 6-dione derivatives against breast carcinoma. Curr Cancer Drug Targets 2018; 18: 372–81.
Singh K, Kaur H, Chibale K, et al. 2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies. Eur J Med Chem 2012; 52: 82–97.
Alemi Serej F, Mahdavi M, Zare P, et al. Biological evaluation of aminopyrimidines derivatives as growth inhibitor and apoptosis inducer of K562 chronic myeloid leukemia cells. J Mazandaran Univ Med Sci 2014; 24: 1–10.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
